These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 24029937)

  • 1. Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.
    Honardoust D; Kwan P; Momtazi M; Ding J; Tredget EE
    Methods Mol Biol; 2013; 1037():203-31. PubMed ID: 24029937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced decorin, fibromodulin, and transforming growth factor-β3 in deep dermis leads to hypertrophic scarring.
    Honardoust D; Varkey M; Marcoux Y; Shankowsky HA; Tredget EE
    J Burn Care Res; 2012; 33(2):218-27. PubMed ID: 22079916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo.
    Ding J; Ma Z; Liu H; Kwan P; Iwashina T; Shankowsky HA; Wong D; Tredget EE
    Wound Repair Regen; 2014; 22(5):622-30. PubMed ID: 25139227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep dermal fibroblasts refractory to migration and decorin-induced apoptosis contribute to hypertrophic scarring.
    Honardoust D; Ding J; Varkey M; Shankowsky HA; Tredget EE
    J Burn Care Res; 2012; 33(5):668-77. PubMed ID: 22210076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.
    Honardoust D; Varkey M; Hori K; Ding J; Shankowsky HA; Tredget EE
    Wound Repair Regen; 2011; 19(3):368-78. PubMed ID: 21518082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes.
    Varkey M; Ding J; Tredget EE
    Tissue Eng Part A; 2014 Feb; 20(3-4):716-27. PubMed ID: 24090416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar.
    Varkey M; Ding J; Tredget EE
    Biomaterials; 2011 Oct; 32(30):7581-91. PubMed ID: 21802722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of TGF-β1 and IFN-α2b on decorin, decorin isoforms and type I collagen in hypertrophic scar dermal fibroblasts.
    Eremenko EE; Kwan PO; Ding J; Ghosh S; Tredget EE
    Wound Repair Regen; 2024; 32(2):135-145. PubMed ID: 38243615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells.
    Ding J; Ma Z; Shankowsky HA; Medina A; Tredget EE
    Wound Repair Regen; 2013; 21(3):448-55. PubMed ID: 23627585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar.
    Kwan P; Ding J; Tredget EE
    PLoS One; 2015; 10(4):e0123054. PubMed ID: 25837671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural behavior of mononuclear phagocytes in HTS formation.
    Zhu Z; Ding J; Ma Z; Iwashina T; Tredget EE
    Wound Repair Regen; 2016; 24(1):14-25. PubMed ID: 26519112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.
    Zhang Z; Li XJ; Liu Y; Zhang X; Li YY; Xu WS
    Burns; 2007 Aug; 33(5):634-41. PubMed ID: 17374457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar.
    Momtazi M; Kwan P; Ding J; Anderson CC; Honardoust D; Goekjian S; Tredget EE
    Wound Repair Regen; 2013; 21(1):77-87. PubMed ID: 23126488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against TGF-β1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring.
    Shi JH; Guan H; Shi S; Cai WX; Bai XZ; Hu XL; Fang XB; Liu JQ; Tao K; Zhu XX; Tang CW; Hu DH
    Arch Dermatol Res; 2013 May; 305(4):341-52. PubMed ID: 23321694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process.
    Wang J; Ding J; Jiao H; Honardoust D; Momtazi M; Shankowsky HA; Tredget EE
    Wound Repair Regen; 2011; 19(2):274-85. PubMed ID: 21362096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars.
    Bellemare J; Roberge CJ; Bergeron D; Lopez-Vallé CA; Roy M; Moulin VJ
    J Pathol; 2005 May; 206(1):1-8. PubMed ID: 15772942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermis, acellular dermal matrix, and fibroblasts from different layers of pig skin exhibit different profibrotic characteristics: evidence from in vivo study.
    Zuo Y; Lu S
    Oncotarget; 2017 Apr; 8(14):23613-23627. PubMed ID: 28423561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
    Chawla S; Ghosh S
    Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep dermal fibroblasts contribute to hypertrophic scarring.
    Wang J; Dodd C; Shankowsky HA; Scott PG; Tredget EE;
    Lab Invest; 2008 Dec; 88(12):1278-90. PubMed ID: 18955978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.